Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · IEX Real-Time Price · USD
0.969
-0.081 (-7.70%)
Jul 22, 2024, 10:06 AM EDT - Market open
RVPH Employees
Reviva Pharmaceuticals Holdings had 15 employees as of December 31, 2023. The number of employees increased by 5 or 50.00% compared to the previous year.
Employees
15
Change (1Y)
5
Growth (1Y)
50.00%
Revenue / Employee
n/a
Profits / Employee
-$2,672,793
Market Cap
28.92M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 15 | 5 | 50.00% |
| Dec 31, 2022 | 10 | 5 | 100.00% |
| Dec 31, 2021 | 5 | 0 | - |
| Dec 31, 2020 | 5 | 1 | 25.00% |
| Dec 31, 2019 | 4 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Cutera | 430 |
| IRIDEX | 111 |
| ImmuCell | 79 |
| NKGen Biotech | 63 |
| Equillium | 44 |
| Quince Therapeutics | 32 |
| MiNK Therapeutics | 31 |
| Longeveron | 24 |
RVPH News
- 13 days ago - Reviva Announces Grant of European Patent Covering Use of Brilaroxazine for the Treatment of Pulmonary Hypertension - GlobeNewsWire
- 7 weeks ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Reviva Pharmaceuticals Holdings, Inc. - RVPH - Accesswire
- 7 weeks ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Reviva Pharmaceuticals Holdings, Inc. - RVPH - PRNewsWire
- 7 weeks ago - Reviva Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 7 weeks ago - Reviva Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 2 months ago - Reviva to Participate in the BIO International Convention - GlobeNewsWire
- 2 months ago - Reviva Announces Enrollment Update for Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia - GlobeNewsWire
- 2 months ago - Reviva Reports First Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewsWire